DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,194 filers reported holding DANAHER CORPORATION in Q4 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,943,195 | +6.6% | 44,108 | +3.1% | 0.20% | +10.5% |
Q2 2023 | $10,266,480 | -1.4% | 42,777 | +3.6% | 0.18% | -6.2% |
Q1 2023 | $10,409,252 | -8.8% | 41,300 | -4.0% | 0.19% | -13.1% |
Q4 2022 | $11,418,369 | +7.5% | 43,020 | +4.6% | 0.22% | -3.5% |
Q3 2022 | $10,626,000 | +4.3% | 41,139 | +2.4% | 0.23% | +7.0% |
Q2 2022 | $10,187,000 | -15.6% | 40,180 | -2.4% | 0.22% | -0.5% |
Q1 2022 | $12,072,000 | -12.0% | 41,155 | -1.3% | 0.22% | -4.4% |
Q4 2021 | $13,716,000 | +7.5% | 41,688 | -0.6% | 0.23% | -0.4% |
Q3 2021 | $12,762,000 | +14.1% | 41,921 | +0.6% | 0.23% | +5.1% |
Q2 2021 | $11,183,000 | +23.0% | 41,672 | +3.2% | 0.22% | +16.8% |
Q1 2021 | $9,093,000 | -1.6% | 40,397 | -2.9% | 0.18% | -4.1% |
Q4 2020 | $9,240,000 | +7.7% | 41,593 | +4.4% | 0.19% | -4.5% |
Q3 2020 | $8,580,000 | +26.5% | 39,844 | +3.9% | 0.20% | +20.2% |
Q2 2020 | $6,780,000 | +28.0% | 38,342 | +0.2% | 0.17% | +9.1% |
Q1 2020 | $5,296,000 | +2.2% | 38,259 | +13.3% | 0.15% | +27.3% |
Q4 2019 | $5,183,000 | +0.9% | 33,771 | -5.0% | 0.12% | -6.2% |
Q3 2019 | $5,137,000 | +16.9% | 35,565 | +15.7% | 0.13% | +12.2% |
Q2 2019 | $4,395,000 | +34.2% | 30,752 | +24.0% | 0.12% | +30.7% |
Q1 2019 | $3,274,000 | +44.1% | 24,797 | +12.5% | 0.09% | +25.7% |
Q4 2018 | $2,272,000 | -3.2% | 22,032 | +2.0% | 0.07% | +6.1% |
Q3 2018 | $2,347,000 | +6.4% | 21,599 | -3.3% | 0.07% | -1.5% |
Q2 2018 | $2,205,000 | +15.7% | 22,340 | +14.8% | 0.07% | +13.6% |
Q1 2018 | $1,906,000 | +25.1% | 19,467 | +18.6% | 0.06% | +31.1% |
Q4 2017 | $1,523,000 | +32.0% | 16,412 | +22.0% | 0.04% | +25.0% |
Q3 2017 | $1,154,000 | -0.3% | 13,454 | -2.0% | 0.04% | +2.9% |
Q2 2017 | $1,158,000 | +15.2% | 13,727 | +16.8% | 0.04% | +12.9% |
Q1 2017 | $1,005,000 | +11.0% | 11,756 | +1.1% | 0.03% | +6.9% |
Q4 2016 | $905,000 | -0.8% | 11,633 | 0.0% | 0.03% | -6.5% |
Q3 2016 | $912,000 | -22.4% | 11,633 | 0.0% | 0.03% | -24.4% |
Q2 2016 | $1,175,000 | +4.0% | 11,633 | -2.4% | 0.04% | +2.5% |
Q1 2016 | $1,130,000 | +8.7% | 11,918 | +6.3% | 0.04% | -9.1% |
Q4 2015 | $1,040,000 | -2.3% | 11,208 | -10.4% | 0.04% | -8.3% |
Q3 2015 | $1,065,000 | -3.4% | 12,502 | -2.9% | 0.05% | +4.3% |
Q2 2015 | $1,102,000 | +1.1% | 12,873 | +0.3% | 0.05% | +2.2% |
Q1 2015 | $1,090,000 | -0.9% | 12,833 | 0.0% | 0.04% | -2.2% |
Q4 2014 | $1,100,000 | +32.9% | 12,833 | +17.8% | 0.05% | +24.3% |
Q3 2014 | $828,000 | -6.1% | 10,893 | -2.8% | 0.04% | -2.6% |
Q2 2014 | $882,000 | -2.8% | 11,205 | -7.3% | 0.04% | -5.0% |
Q1 2014 | $907,000 | -10.6% | 12,090 | -8.0% | 0.04% | -11.1% |
Q4 2013 | $1,014,000 | +20.6% | 13,140 | +5.8% | 0.04% | +15.4% |
Q3 2013 | $841,000 | +13.2% | 12,417 | +5.7% | 0.04% | +14.7% |
Q2 2013 | $743,000 | – | 11,747 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |